Evidence map›Paper›PMID 8981085›Full record

ArticleGlycoconjugate journal1996

Involvement of sphingolipids metabolites in cellular proliferation modulated by ganglioside GM1.

F Wang, N E Buckley, A Olivera, K A Goodemote, Y Su, S Spiegel

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

F WangDepartment of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
N E Buckley
A Olivera
K A Goodemote
Y Su
S Spiegel
Georgetown University · USGeorgetown University Medical Center · US

Funding

Sphingosine Kinases in Cancer Cell SignalingR01CA061774 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SPIEGEL, SARAH · 1994 to 2015
$3.8M
NCI NIH HHS CA61774
6 · The paper itself

Abstract

The B subunit of cholera toxin, which binds specifically to ganglioside GM1, is mitogenic for quiescent Swiss 3T3 fibroblasts. Recently, sphingolipids metabolites, ceramide, sphingosine and sphingosine-1-phosphate, have been implicated as second messengers in cell growth regulation and differentiation. In this paper, we examined the possibility that interaction of the B subunit with membrane GM1 leads to alterations in metabolism of glycosphingolipids and that increased levels of sphingolipids metabolites may mediate the biological effects of the B subunit. While the B subunit did not induce a change in the level of ceramide or sphingosine, the level of sphingosine-1-phosphate was rapidly and transiently increased. The B subunit also transiently activated cytosolic sphingosine kinase activity, which catalyzes the phosphorylation of the primary hydroxyl group of sphingosine to produce sphingosine-1-phosphate. To determine whether the increase in sphingosine-1-phosphate level plays a role in B subunit-induced mitogenicity, we used a competitive inhibitor of sphingosine kinase, D,L-threo-dihydrosphingosine. D,L-thereo-Dihydrosphingosine not only inhibited B subunit-induced DNA synthesis by 26%, it also reduced its ability to stimulate DNA-binding activity of the transcription factor AP-1. This sphingosine kinase inhibitor also inhibited B subunit-induced increases in the activity of cell cycle-regulated, cyclin-dependent serine/threonine kinases, cdk2 and p34cdc2. These findings suggest that sphingosine-1-phosphate may play a role in the signal transduction pathways activated by binding of the B subunit to endogenous ganglioside GM1.

Indexed as

CDC2-CDC28 KinasesLysophospholipids3T3 CellsAnimalsAntibodiesBinding, CompetitiveCDC2 Protein KinaseCell DivisionCeramidesCholera ToxinCyclin-Dependent Kinase 2Cyclin-Dependent KinasesDNAEnzyme ActivationEnzyme InhibitorsEpidermal Growth FactorAntibodiesCDC2-CDC28 KinasesCDC2 Protein KinaseCdk2 protein, mouseCeramidesCholera Toxincholera toxin B subunit (50-75)Cyclin-Dependent Kinase 2Cyclin-Dependent KinasesDNAEnzyme InhibitorsEpidermal Growth FactorG(M1) GangliosideLysophospholipidsMitogensPeptide FragmentsPhosphotransferases (Alcohol Group Acceptor)Platelet-Derived Growth FactorProtein Serine-Threonine KinasessafingolSphingolipidsSphingosinesphingosine 1-phosphateSphingosine KinaseTetradecanoylphorbol AcetateTranscription Factor AP-1

Identifiers

PMID8981085
OpenAlexW2037231703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.